Cost-Effectiveness of Early Oral Feeding Following Total Gastrectomy
Autor: | Akinori Hisashige, Yasuyuki Seto, Nobuyuki Shimizu |
---|---|
Rok vydání: | 2020 |
Předmět: |
medicine.medical_specialty
Cost effectiveness business.industry medicine.medical_treatment General Medicine law.invention 03 medical and health sciences 0302 clinical medicine Randomized controlled trial Quality of life law 030220 oncology & carcinogenesis Value for money Internal medicine medicine Gastrectomy 030212 general & internal medicine Limited evidence Special diet business Oral feeding |
Zdroj: | Global Journal of Health Science. 13:64 |
ISSN: | 1916-9744 1916-9736 |
DOI: | 10.5539/gjhs.v13n1p64 |
Popis: | BACKGROUND: Gastric cancer is a major health problem worldwide. Effectiveness of early oral feeding (EOF) following gastrectomy has been internationally evaluated, even though there is limited evidence available. In Japan, recently, a randomized controlled trial of EOF following total gastrectomy showed a decreased length of hospital stay, compared with conventional oral feeding (COF). To evaluate value for money of EOF following gastrectomy, cost-effective analysis was carried out based on this trial. METHODS: The analysis was carried out from a societal perspective as the base case. The subjects were randomly assigned to the EOF group (N=32) and the COF group (N=30). While the EOF group received a special diet (i.e., iEAT) from the postoperative day (POD) 1 to POD 3, the COF group received conventional diet (i.e., a liquid diet or rice gruel) on POD 4 and thereafter. The observation period was 3 weeks after total gastrectomy. As an effectiveness measure, quality-adjusted life days (QALDs) were estimated. Quality of life for health conditions was evaluated by using EuroQol-5Dimentions (EQ-5D)-3Levels among the subjects. Costs (e.g., nutritional support, hospitalization and treatment of adverse events) were estimated from trial data during observation. Qualitative and stochastic sensitivity analyses were performed to examine the robustness of the results. RESULTS: The mean QALDs per patient for the EOF and the COF groups were 14.93 and 14.19, respectively. Incremental effectiveness of the EOF group to the COF group was 0.74 QALDs (p=0.359, t-test). The mean total cost per patient in the EOF and the COF groups was $3,177.7 and $3,755.4, respectively. Incremental cost was -$577.7 (p=0.03, t-test, Welch). This means EOF is dominant (cost saving). The qualitative sensitivity analysis and the stochastic sensitivity analysis showed the relative robustness of these results. CONCLUSIONS: Economic evaluation of EOF following total gastrectomy showed that EOF was cost-saving, with non-significant increase in effectives (i.e., QALD), compared with COF. This result can contribute to strengthen the evidence for wide use of EOF. |
Databáze: | OpenAIRE |
Externí odkaz: |